These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28359805)

  • 1. [Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].
    Azaïs H; Frochot C; Grabarz A; Khodja Bach S; Colombeau L; Delhem N; Mordon S; Collinet P
    Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):190-196. PubMed ID: 28359805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the specificity of a new folate-targeted photosensitizer for peritoneal metastasis of epithelial ovarian cancer to enable intraperitoneal photodynamic therapy. A preclinical study.
    Azaïs H; Schmitt C; Tardivel M; Kerdraon O; Stallivieri A; Frochot C; Betrouni N; Collinet P; Mordon S
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():130-138. PubMed ID: 26200606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal photodynamic therapy for peritoneal metastasis of epithelial ovarian cancer. Limits and future prospects].
    Azaïs H; Mordon S; Collinet P
    Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):249-256. PubMed ID: 28373041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fischer 344 Rat: A Preclinical Model for Epithelial Ovarian Cancer Folate-Targeted Therapy.
    Azaïs H; Queniat G; Bonner C; Kerdraon O; Tardivel M; Jetpisbayeva G; Frochot C; Betrouni N; Collinet P; Mordon S
    Int J Gynecol Cancer; 2015 Sep; 25(7):1194-200. PubMed ID: 26244757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [FRα: a target for prophylactic photodynamic therapy of ovarian peritoneal metastasis?].
    Azaïs H; Moussaron A; Khodja Bach S; Bassil A; Betrouni N; Frochot C; Collinet P; Mordon S
    Bull Cancer; 2014 Dec; 101(12):1109-13. PubMed ID: 25532689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microscopic peritoneal metastases of epithelial ovarian cancers. Clinical relevance, diagnostic and therapeutic tools].
    Kerbage Y; Canlorbe G; Estevez JP; Grabarz A; Mordon S; Uzan C; Collinet P; Azaïs H
    Gynecol Obstet Fertil Senol; 2018 May; 46(5):497-502. PubMed ID: 29656069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy of ovarian cancer peritoneal metastasis with hexaminolevulinate: a toxicity study.
    Guyon L; Farine MO; Lesage JC; Gevaert AM; Simonin S; Schmitt C; Collinet P; Mordon S
    Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):265-74. PubMed ID: 24784431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
    Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
    Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation.
    Boidin L; Moinard M; Moussaron A; Merlier M; Moralès O; Grolez GP; Baydoun M; Mohd-Gazzali A; Tazizi MHDM; Allah HHA; Kerbage Y; Arnoux P; Acherar S; Frochot C; Delhem N
    J Control Release; 2024 Jul; 371():351-370. PubMed ID: 38789088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate Receptor Targeted Photodynamic Therapy: A Novel Way to Stimulate Anti-Tumor Immune Response in Intraperitoneal Ovarian Cancer.
    Baydoun M; Boidin L; Leroux B; Vignion-Dewalle AS; Quilbe A; Grolez GP; Azaïs H; Frochot C; Moralès O; Delhem N
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge.
    Azaïs H; Estevez JP; Foucher P; Kerbage Y; Mordon S; Collinet P
    Surg Oncol; 2017 Mar; 26(1):46-52. PubMed ID: 28317584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global approach for the development of photodynamic therapy of peritoneal metastases regardless of their origin.
    Azaïs H; Rebahi C; Baydoun M; Serouart B; Ziane L; Moralès O; Frochot C; Colombeau L; Thécua E; Collinet P; Delhem N; Mordon S
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101683. PubMed ID: 32061747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer.
    Yokoyama Y; Shigeto T; Miura R; Kobayashi A; Mizunuma M; Yamauchi A; Futagami M; Mizunuma H
    Asian Pac J Cancer Prev; 2016; 17(2):775-9. PubMed ID: 26925679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC).
    Seifert H; Georgiou A; Alexander H; McLachlan J; Bodla S; Kaye S; Barton D; Nobbenhuis M; Gore M; Banerjee S
    Gynecol Oncol; 2015 Nov; 139(2):216-20. PubMed ID: 26318078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
    Zivanovic O; Abramian A; Kullmann M; Fuhrmann C; Coch C; Hoeller T; Ruehs H; Keyver-Paik MD; Rudlowski C; Weber S; Kiefer N; Poelcher ML; Thiesler T; Rostamzadeh B; Mallmann M; Schaefer N; Permantier M; Latten S; Kalff J; Thomale J; Jaehde U; Kuhn WC
    Int J Cancer; 2015 Feb; 136(3):699-708. PubMed ID: 24895230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model.
    Estevez JP; Ascencio M; Colin P; Farine MO; Collinet P; Mordon S
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):251-7. PubMed ID: 21112548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
    Skaznik-Wikiel ME; Lesnock JL; McBee WC; Beriwal S; Zorn KK; Richard SD; Krivak TC; Edwards RP
    Int J Gynecol Cancer; 2012 Feb; 22(2):232-7. PubMed ID: 22080886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
    Ascencio M; Collinet P; Farine MO; Mordon S
    Lasers Surg Med; 2008 Jul; 40(5):332-41. PubMed ID: 18563777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether.
    Song K; Kong B; Li L; Yang Q; Wei Y; Qu X
    Cancer Sci; 2007 Dec; 98(12):1959-64. PubMed ID: 17900310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.
    Hornung R; Fehr MK; Monti-Frayne J; Tromberg BJ; Berns MW; Tadir Y
    Br J Cancer; 1999 Oct; 81(4):631-7. PubMed ID: 10574248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.